Description of the goods or services required
Coronavirus rapid response call - Active intervention development
The Department of Health and Social Care, through the NIHR, and UK Research and Innovation (UKRI) have jointly launched two rapid response research calls to tackle the 2019 novel coronavirus (2019-nCoV).
The first call invites applications for UK-led academic, small- and medium-sized enterprise (SME) and wider industry research that will develop interventions to address 2019-nCoV.
Short term (up to 18 month) proposals are sought that could make a significant contribution to the understanding, diagnosis, prevention and/or management of the 2019-nCoV outbreak.
The scope for this call encompasses:
•Vaccines, with prioritisation of those with potential for rapid clinical development: ◦Novel candidates
◦Existing vaccines showing cross-reactivity to nCoV-2019
•Therapeutics, with prioritisation of those with potential for rapid clinical development: ◦Re-purposing of existing therapeutics, e.g. proteases, helicases or entry inhibitors
◦Development of mAbs or other biologics